Attention: Mesoblast Share Shorters, page-49

Rather than obsessing about shorting, I would suggest getting the story of the NIH's abysmal trialing of Rem-L out there on reddit. We are seeing the implications of a mutating COVID-19 virus (see S.Africa and Astra Zenica) having repercussions for the vaccines that were going to solve everything (sarcasm). That the world has probably been denied a very credible treatment (and C-19 always needed to be a three pronged approach of social actions, vaccines and treatments) because of some basically appalling sample control in its trials is a tragedy.

Not for my holding, but more for humanity, I am still hoping on the outside chance that Novartis does an emergency C-19 ARDS trial in the EU (the Dutch did an ARDS trial in a month at the height of the crisis there) and can prove some efficacy so this treatment can be the first port of call in treatment C-19 ARDS patients and make a difference to the tens of thousands that still die daily....